Clinical significance of perioperative changes in ankle-brachial index with regard to extremity-related outcome in non-diabetic patients with critical limb ischemia

PurposeTo evaluate the significance of perioperative changes in ankle-brachial index (ABI) with regard to extremity-related outcome in non-diabetic patients with critical limb ischemia (CLI) following revascularization.MethodsThe study represents a subanalysis of the multicentric Registry of First-l...

Full description

Saved in:
Bibliographic Details
Main Authors: Bischoff, Moritz (Author) , Meisenbacher, Katrin (Author) , Peters, Andreas (Author) , Kronsteiner, Dorothea (Author) , Böckler, Dittmar (Author)
Format: Article (Journal)
Language:English
Published: 17 June 2018
In: Langenbeck's archives of surgery
Year: 2018, Volume: 403, Issue: 6, Pages: 741-748
ISSN:1435-2451
DOI:10.1007/s00423-018-1689-7
Online Access:Verlag, Volltext: https://doi.org/10.1007/s00423-018-1689-7
Get full text
Author Notes:Moritz S. Bischoff, K. Meisenbacher, A. S. Peters, D. Weber, T. Bisdas, G. Torsello, D. Böckler, for the CRITISCH collaborators
Description
Summary:PurposeTo evaluate the significance of perioperative changes in ankle-brachial index (ABI) with regard to extremity-related outcome in non-diabetic patients with critical limb ischemia (CLI) following revascularization.MethodsThe study represents a subanalysis of the multicentric Registry of First-line Treatment in Patients with CLI (CRITISCH). After exclusion of diabetic patients, conservative cases, and primary major amputation, 563 of 1200 CRITISCH patients (mean age 74 ± 10.7 years) were analyzed. This population was divided into two groups regarding perioperative ABI changes ∆ + 0.15 (Group 1) or ∆ − 0.15 (Group 2). Study endpoints were reintervention and major amputation during a mean follow-up of 14.6 ± 9 months. Logistic regression was performed in order to identify factors for ABI group affiliation.ResultsThere were 279 patients in Group 1 (49.5%) and 284 in Group 2 (51.5%). ABI sensitivity and specificity regarding vessel patency were calculated to be 54 and 87%. A preoperative ABI ≤ 0.4 [odds ratio (OR) 7.7], patent vessels at discharge (OR 12.2), and secondary interventions (OR 2.4) were identified as factors for Group 1 affiliation. Contrariwise, previous revascularization (OR 0.6), a glomerular filtration rate ≤ 15 ml/min/1.73 m2 (OR 0.3), and TASC A lesions (OR 0.2) were associated with Group 2 affiliation. No statistical difference was found with regard to the need of reintervention. However, time to reintervention was significantly shorter in Group 2 compared to that in Group 1 (10.0 ± 9.5 months vs 12.1 ± 9.1 months; p = 0.005). Amputation rate in Group 2 was 14.4%, significantly higher compared to that in Group 1 (6.0%; p < 0.0001).ConclusionsFailure of perioperative ABI improvement is associated with a higher probability for amputation and should be valued as prognostic factor in non-diabetic patients with CLI. Patients with no/marginal improvement in ABI after revascularization require close follow-up monitoring and may benefit from early reintervention.
Item Description:Gesehen am 10.09.2019
Physical Description:Online Resource
ISSN:1435-2451
DOI:10.1007/s00423-018-1689-7